Effects of synthetic peptides on giant neurons identified in the ganglia of an African giant snail (Achatina fulica Férussac)--II. 1987

A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi

Thirteen synthetic biologically-active peptides, which were classified into the peptides proposed as neurotransmitters in mammals and invertebrates and neural venom peptides, were investigated for their effects on the following six identifiable giant neurons of an African giant snail (Achatina fulica Férussac): RAPN (right anterior pallial neuron), INN (intestinal nerve neuron), RPeNLN (right pedal nerve large neuron), LPeNLN (left pedal nerve large neuron), d-LPeLN (dorsal-left pedal large neuron) and d-LPeCN (dorsal-left pedal constantly firing neuron). Oxytocin and proctolin at 10(-4)M excited the RAPN membrane potential, whereas FMRFamide at the same concentration inhibited the same neuron. FMRFamide at 10(-4)M markedly inhibited the d-LPeLN membrane potential, sometimes produced inhibition of RPeNLN and LPeNLN, showed varied effects (excitatory or inhibitory) on INN, and had no effect on d-LPeCN. The other peptides examined had almost no effect on any of the neurons tested.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005724 Ganglia Clusters of multipolar neurons surrounded by a capsule of loosely organized CONNECTIVE TISSUE located outside the CENTRAL NERVOUS SYSTEM.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012908 Snails Marine, freshwater, or terrestrial mollusks of the class Gastropoda. Most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man. Snail
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
January 1985, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
January 1988, Comptes rendus des seances de la Societe de biologie et de ses filiales,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
January 1988, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
January 1988, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
September 1994, Fiziologicheskii zhurnal imeni I.M. Sechenova,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
August 1985, European journal of pharmacology,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
May 1986, Brain research,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
January 1988, Comptes rendus des seances de la Societe de biologie et de ses filiales,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
September 1977, Neuropharmacology,
A Yongsiri, and K H Kim, and H Takeuchi, and N Yanaihara, and E Munekata, and Y Ariyoshi
April 1985, European journal of pharmacology,
Copied contents to your clipboard!